Stroke Prevention in Nigeria 2 Trial

NCT06526117 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

220

Enrollment

OTHER

Sponsor class

Conditions

Sickle Cell Disease
Stroke

Interventions

DRUG: Hydroxyurea

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]
[object Object]
[object Object]